Welcome to the latest episode from Henry Jennings at Marcustoday. In this podcast, my guest is Andrew Elf, CEO of Mitchell Services. A long established mining services company with a good growth profile and strong balance sheet.

Andrew has been CEO since 2014 and in the last four years has paid down the debt and is no debt free and has cash in the bank. Plus it is paying a 6c Fully Franked dividend.

A good look inside a cyclical sector that has been in the doldrums for a while.

Marcus Today – Daily Market Insights

Marcus Today provides clear, practical commentary for self-directed investors – covering markets, portfolios, education, and decision-making without the noise.

If you'd like to go further:

Start a free 14-day trial of Marcus Today
http://bit.ly/mt-trial-podcast

Join Marcus Today
Use code MTPODCAST for 10% off
http://bit.ly/mt-join-podcast-offer

MT20 – Managed ETF Portfolio
A professionally managed portfolio run by Marcus Padley and the team, using ASX-listed ETFs with active market timing.
http://bit.ly/mt20-podcast

Principles – How We Think About Investing
A short video series on timing, behaviour, and decision-making. No stock tips.
http://bit.ly/mt-principles-podcast

,Welcome to another episode of On the Couch, with myself Henry Jennings from Marcus Today. In this episode I am joined by the founder and MD of new ASX listing, Overwatch (OWL).

Oscar Leslie is my guest today and we talk all things maritime security. Defence and border control being two hot button issues currently.

OWL has just raised $8m for a $27m valuation ahead of its debut on Friday 16th.

Marcus Today – Daily Market Insights

Marcus Today provides clear, practical commentary for self-directed investors – covering markets, portfolios, education, and decision-making without the noise.

If you'd like to go further:

Start a free 14-day trial of Marcus Today
http://bit.ly/mt-trial-podcast

Join Marcus Today
Use code MTPODCAST for 10% off
http://bit.ly/mt-join-podcast-offer

MT20 – Managed ETF Portfolio
A professionally managed portfolio run by Marcus Padley and the team, using ASX-listed ETFs with active market timing.
http://bit.ly/mt20-podcast

Principles – How We Think About Investing
A short video series on timing, behaviour, and decision-making. No stock tips.
http://bit.ly/mt-principles-podcast

In this episode of On the Couch, we sit down with Greg Yong CEO of Coast Entertainment (CEH), to discuss the recent results and the growth potential of the land rezoning.

Listeners will know CEH from its days as Ardent Leisure and is the owner of Dreamworld on the Gold Coast.

Greg was appointed Chief Executive Officer of the Theme Parks division in April 2021 and Group Chief Executive Officer in 2023. He has over 20 years’ experience in the theme parks industry in Australia and overseas.

An interesting story and not one that many focus on.

Marcus Today – Daily Market Insights

Marcus Today provides clear, practical commentary for self-directed investors – covering markets, portfolios, education, and decision-making without the noise.

If you'd like to go further:

Start a free 14-day trial of Marcus Today
http://bit.ly/mt-trial-podcast

Join Marcus Today
Use code MTPODCAST for 10% off
http://bit.ly/mt-join-podcast-offer

MT20 – Managed ETF Portfolio
A professionally managed portfolio run by Marcus Padley and the team, using ASX-listed ETFs with active market timing.
http://bit.ly/mt20-podcast

Principles – How We Think About Investing
A short video series on timing, behaviour, and decision-making. No stock tips.
http://bit.ly/mt-principles-podcast

—

Disclaimer
This podcast is general information only and does not consider your personal circumstances. It is not personal financial advice.

Welcome to the latest On the Couch. In this episode I am catching up with Chris Burns, the CEO and MD of Amplia Therapeutics (ATX).

Chris is an experienced drug discovery leader having worked in various roles in pharma, biotech and academia for 25 years.

He has a Ph.D. from the University of Melbourne and is the inventor on over 30 patents and a co-author on over 60 scientific publications. He was co-recipient of the 2024 Prime Minister’s Prize for Innovation and is a Fellow of the Australian Academy of Health and Medical Sciences, the Royal Society of Chemistry (UK) and the Royal Australian Chemical Institute.

Dr Burns was originally appointed as a Non-Executive Director on 4 May 2018 and was subsequently appointed as Chief Executive Officer and Managing Director on 5 December 2022.

Amplia Therapeutics Limited (ATX) is an Australian, clinical-stage, drug development company focused on the development of two potent, orally-available inhibitors of Focal Adhesion Kinase (FAK) for the treatment of cancer and fibrotic diseases.​